NFE2L2 and multiple sclerosis: Previous studies have demonstrated that NRF2 activators are useful for treatment of various oxidative stress-related diseases, and a number of NRF2 chemical activators are currently undergoing clinical trials for treatment of multiple sclerosis, cardiovascular disease, diabetes mellitus, and psoriasis [11].